Friday, August 31, 2007

Las Vegas-based Phage Biotechnology Corporation Receives Approval from CA

Phage Biotechnology Corporation with headquarters in Las Vegas received word from the State of California Department of Public Health that Phage was approved for a license to manufacture drugs at its San Diego facility. The approval came in August, 2007. Phage Biotechnology manufactures bio-similar proteins. The company will use the facility to make Interferon Alpha, Beta-interferon, Human Growth hormone, Parathyroid hormone, Neupogen and Fibroblast Growth Factor. Phage manufactures protein pharmaceuticals that utilize a proprietary process in which recombinant proteins can be produced relatively rapidly and at low cost utilizing the Phage manufacturing process.

Sunday, August 19, 2007

John Laub is the New President of NevBio

John Laub has accepted the position as the Executive Director of the Nevada Biotechnology and Bioscience Consortium (NevBio). John was one of the founders of NevBio and stepped in to replace Dr. Jennifer Montague, who had to resign due to her husband’s relocation to North Carolina. John is also the Executive Director of the Regenerative Medicine Organization, which is an international, non-profit organization dedicated to the advancement of regenerative medicine. The Regenerative Medicine Organization holds its annual conference in Las Vegas each year. John has lived in Las Vegas for over forty years and is dedicated to developing the Life Science community in Las Vegas.